Loading...
XHELPIHLIS
Market cap245mUSD
Dec 20, Last price  
10.45EUR
1D
-0.95%
1Q
5.98%
Jan 2017
-43.27%
IPO
-18.87%
Name

Pihlajalinna Oyj

Chart & Performance

D1W1MN
XHEL:PIHLIS chart
P/E
55.46
P/S
0.33
EPS
0.19
Div Yield, %
0.63%
Shrs. gr., 5y
0.30%
Rev. gr., 5y
8.10%
Revenues
720m
+4.27%
47,300,000104,400,000173,850,000213,327,000399,092,000423,984,000487,764,000518,596,000508,682,000577,774,000690,481,000719,984,000
Net income
6m
-39.82%
1,100,0004,400,0001,713,000464,0008,049,0009,515,0003,826,0003,365,0008,687,00020,095,0009,519,0005,729,000
CFO
79m
+21.76%
016,425,9999,402,00015,703,00031,190,00033,243,00037,704,00036,840,00047,185,00056,936,00064,882,00079,002,000
Dividend
Apr 11, 20240.07 EUR/sh
Earnings
Feb 12, 2025

Profile

Pihlajalinna Oyj provides social and healthcare services for private persons, companies, insurance companies, municipalities, and hospital districts in Finland. It offers general practitioner and medical specialist services, occupational healthcare, social and healthcare outsourcing, fitness center services, responsible doctor, and remote consultation services, as well as residential and staffing services. Its specialized care and services, include geriatrics, gynecology, psychiatry, youth psychiatry, neurology, internal medicine, radiology, general medicine, opaedics and surgery, internal medicine, urology, cardiology, surgery, plastic surgery, internal medicine cardiology, lung diseases, dialysis, ENT, and orthopedics, as well as emergency and on-call, dental care, substance abuse clinic, and family service center services. Pihlajalinna Oyj was founded in 2001 and is headquartered in Tampere, Finland.
IPO date
Jun 08, 2015
Employees
7,479
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
719,984
4.27%
690,481
19.51%
577,774
13.58%
Cost of revenue
585,902
274,595
218,310
Unusual Expense (Income)
NOPBT
134,082
415,886
359,464
NOPBT Margin
18.62%
60.23%
62.22%
Operating Taxes
3,587
(6,110)
5,130
Tax Rate
2.68%
1.43%
NOPAT
130,495
421,996
354,334
Net income
5,729
-39.82%
9,519
-52.63%
20,095
131.32%
Dividends
(1,480)
(8,589)
(4,932)
Dividend yield
0.93%
4.46%
1.73%
Proceeds from repurchase of equity
(1,475)
(4,390)
BB yield
0.77%
1.54%
Debt
Debt current
33,750
31,428
19,675
Long-term debt
574,432
598,266
284,944
Deferred revenue
20,000
134
Other long-term liabilities
21,324
1,478
1,607
Net debt
583,665
598,698
288,096
Cash flow
Cash from operating activities
79,002
64,882
56,936
CAPEX
(22,859)
(29,033)
(14,833)
Cash from investing activities
(18,460)
(83,439)
(32,064)
Cash from financing activities
(49,153)
27,429
(33,923)
FCF
252,423
246,882
363,413
Balance
Cash
24,517
13,128
4,257
Long term investments
17,868
12,266
Excess cash
Stockholders' equity
124,591
122,888
122,611
Invested Capital
523,509
524,458
319,440
ROIC
24.90%
100.01%
110.42%
ROCE
25.21%
78.03%
110.49%
EV
Common stock shares outstanding
22,558
22,589
22,589
Price
7.07
-17.02%
8.52
-32.59%
12.64
34.75%
Market cap
159,485
-17.13%
192,462
-32.59%
285,530
34.77%
EV
739,705
790,068
577,136
EBITDA
185,988
461,384
394,165
EV/EBITDA
3.98
1.71
1.46
Interest
11,549
6,831
3,432
Interest/NOPBT
8.61%
1.64%
0.95%